Nifty

:

18210.95

Sensex

:

61143.33

-57.45 (-0.31%)
-206.93 (-0.34%)

Login

Nifty
Sensex

:
:

18210.95
61143.33

-57.45 (-0.31%)
-206.93 (-0.34%)

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :

31/99

BSE: 506690 | NSE: UNICHEMLAB

Watchlist

NSE BSE

242.80

26-Oct-2021

Open
High
Low
Previous Close

237.05
246.50
231.90
235.85

Volume
Traded Value (lacs)
52 Week High
52 Week Low

52135
124.19
375.00
218.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,701.35
84.50
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,719.53
1.66%
0.68

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

3.50
-4.32
1.30

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-2.39
-12.97
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-6.95
-20.40
83.17

P:E (Median)

8 Years
5 Years
3 Years

17.16
0.64
-

P:BV (Average)

8 Years
5 Years
3 Years

1.87
1.49
0.61

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.38
25.02
35.05

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 200.80 240.77 -16.60% 261.09 215.63 21.08% 311.18 231.19 34.60% 310.93 225.10 38.13%
Expenses 229.50 248.58 -7.68% 233.29 226.60 2.95% 279.54 256.90 8.81% 267.09 260.92 2.36%
EBITDA -28.70 -7.81 - 27.79 -10.98 - 31.64 -25.70 - 43.84 -35.82 -
EBIDTM -14.29% -3.24% 10.65% -5.09% 10.17% -11.12% 14.10% -15.91%
Other Income 12.54 18.73 -33.05% 4.91 19.13 -74.33% 13.32 23.01 -42.11% 10.41 29.05 -64.17%
Interest 0.12 0.16 -25.00% 0.37 0.59 -37.29% 0.61 0.42 45.24% 0.16 0.23 -30.43%
Depreciation 20.11 18.31 9.83% 19.90 19.11 4.13% 18.75 17.26 8.63% 18.93 17.86 5.99%
PBT -36.38 -7.55 - 12.43 -11.54 - 25.61 -20.37 - 35.16 -24.86 -
Tax -8.55 0.00 - 11.56 0.00 0 -4.82 0.00 - 4.82 0.00 0
PAT -27.83 -7.55 - 0.86 -11.54 - 30.43 -20.37 - 30.34 -24.86 -
PATM -13.86% -3.13% 0.33% -5.35% 9.78% -8.81% 9.76% -11.05%
EPS -3.95 -1.07 - 0.12 -1.64 - 4.32 -2.89 - 4.31 -3.53 -

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 297.91 317.23 -6.09% 274.12 290.20 -5.54% 326.28 274.83 18.72% 317.51 268.14 18.41%
Expenses 299.55 305.15 -1.84% 255.07 276.83 -7.86% 296.17 291.99 1.43% 287.65 294.94 -2.47%
EBITDA -1.64 12.08 - 19.05 13.36 42.59% 30.12 -17.16 - 29.86 -26.81 -
EBIDTM -0.55% 3.81% 6.95% 4.60% 9.23% -6.24% 9.40% -10.00%
Other Income 15.79 16.71 -5.51% 7.83 11.82 -33.76% 15.61 25.10 -37.81% 10.04 28.13 -64.31%
Interest 0.99 1.25 -20.80% 1.81 2.40 -24.58% 1.27 2.32 -45.26% 0.79 1.86 -57.53%
Depreciation 22.12 20.54 7.69% 21.87 22.96 -4.75% 20.82 19.47 6.93% 21.13 20.98 0.71%
PBT -8.96 7.00 - 3.19 -0.17 - 23.64 -13.85 - 17.98 -21.51 -
Tax 2.45 4.61 -46.85% 3.37 17.63 -80.88% -0.07 1.20 - 9.25 0.68 1,260.29%
PAT -11.41 2.39 - -0.17 -17.80 - 23.71 -15.05 - 8.74 -22.19 -
PATM -3.83% 0.75% -0.06% -6.13% 7.27% -5.48% 2.75% -8.27%
EPS -1.63 0.35 - -0.06 -2.44 - 3.35 -2.07 - 1.24 -3.15 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 1,084.00 1,123.97 904.44 975.88 1,231.38 1,418.41 1,220.52 1,090.98 1,044.17 1,005.22 803.19 Net Sales Growth 18.77% 24.27% -7.32% -20.75% -13.19% 16.21% 11.87% 4.48% 3.87% 25.15% Cost Of Goods Sold 405.96 359.33 311.23 339.36 274.57 188.07 395.62 375.39 327.82 335.81 263.68 Gross Profit 678.04 764.64 593.21 636.52 956.81 1,230.34 824.90 715.59 716.36 669.41 539.51 GP Margin 62.55% 68.03% 65.59% 65.23% 77.70% 86.74% 67.59% 65.59% 68.61% 66.59% 67.17% Total Expenditure 1,009.42 1,028.51 995.05 1,034.20 1,214.03 1,252.60 1,078.24 989.74 863.16 823.08 678.06 Power & Fuel Cost - 67.95 72.14 75.43 48.26 40.76 37.34 38.36 34.96 30.55 25.45 % Of Sales - 6.05% 7.98% 7.73% 3.92% 2.87% 3.06% 3.52% 3.35% 3.04% 3.17% Employee Cost - 234.04 205.16 176.76 146.54 117.68 209.60 178.04 147.14 128.01 104.88 % Of Sales - 20.82% 22.68% 18.11% 11.90% 8.30% 17.17% 16.32% 14.09% 12.73% 13.06% Manufacturing Exp. - 138.10 139.62 136.04 115.50 90.53 132.41 129.61 121.78 106.97 91.99 % Of Sales - 12.29% 15.44% 13.94% 9.38% 6.38% 10.85% 11.88% 11.66% 10.64% 11.45% General & Admin Exp. - 164.37 196.55 200.15 566.05 722.03 145.52 132.64 108.27 84.16 72.03 % Of Sales - 14.62% 21.73% 20.51% 45.97% 50.90% 11.92% 12.16% 10.37% 8.37% 8.97% Selling & Distn. Exp. - 61.44 66.88 87.17 52.96 65.40 132.40 127.44 120.75 125.03 110.10 % Of Sales - 5.47% 7.39% 8.93% 4.30% 4.61% 10.85% 11.68% 11.56% 12.44% 13.71% Miscellaneous Exp. - 3.28 3.48 19.29 10.15 28.13 25.35 8.26 2.44 12.55 110.10 % Of Sales - 0.29% 0.38% 1.98% 0.82% 1.98% 2.08% 0.76% 0.23% 1.25% 1.24% EBITDA 74.57 95.46 -90.61 -58.32 17.35 165.81 142.28 101.24 181.01 182.14 125.13 EBITDA Margin 6.88% 8.49% -10.02% -5.98% 1.41% 11.69% 11.66% 9.28% 17.34% 18.12% 15.58% Other Income 41.18 47.37 99.17 101.54 3,280.20 7.19 22.71 20.31 42.96 17.61 11.69 Interest 1.26 1.30 1.28 0.62 3.17 2.00 2.29 2.37 2.48 2.48 3.30 Depreciation 77.69 75.89 71.09 61.71 45.04 39.41 34.99 37.68 42.67 34.82 28.29 PBT 36.82 65.65 -63.81 -19.11 3,249.34 131.60 127.70 81.50 178.82 162.45 105.24 Tax 3.01 11.56 -7.50 -27.91 692.74 27.73 23.69 17.10 43.00 32.85 22.77 Tax Rate 8.17% 17.61% 11.75% 146.05% 21.32% 21.07% 19.08% 20.98% 24.05% 20.22% 21.64% PAT 33.80 54.08 -56.32 8.80 2,556.60 103.87 100.48 64.40 135.82 129.60 82.46 PAT before Minority Interest 33.80 54.08 -56.32 8.80 2,556.60 103.87 100.48 64.40 135.82 129.60 82.46 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.12% 4.81% -6.23% 0.90% 207.62% 7.32% 8.23% 5.90% 13.01% 12.89% 10.27% PAT Growth 152.55% - - -99.66% 2,361.35% 3.37% 56.02% -52.58% 4.80% 57.17% EPS 4.80 7.68 -8.00 1.25 363.15 14.75 14.27 9.15 19.29 18.41 11.71

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 1,215.82 1,235.14 1,103.71 1,188.19 1,379.90 1,540.06 1,332.65 1,201.79 1,133.45 1,080.80 875.46 Net Sales Growth 5.69% 11.91% -7.11% -13.89% -10.40% 15.56% 10.89% 6.03% 4.87% 23.46% Cost Of Goods Sold 371.99 302.14 308.63 364.19 274.97 188.77 386.97 378.57 332.84 343.06 278.55 Gross Profit 843.83 933.00 795.08 823.99 1,104.93 1,351.28 945.67 823.23 800.61 737.75 596.91 GP Margin 69.40% 75.54% 72.04% 69.35% 80.07% 87.74% 70.96% 68.50% 70.63% 68.26% 68.18% Total Expenditure 1,138.44 1,144.03 1,154.53 1,269.21 1,358.21 1,357.62 1,168.77 1,100.79 955.75 910.06 759.42 Power & Fuel Cost - 68.89 73.02 76.39 49.23 41.62 38.25 39.39 35.97 31.36 26.22 % Of Sales - 5.58% 6.62% 6.43% 3.57% 2.70% 2.87% 3.28% 3.17% 2.90% 2.99% Employee Cost - 306.97 273.28 238.52 200.64 169.04 255.92 223.20 187.37 164.88 140.06 % Of Sales - 24.85% 24.76% 20.07% 14.54% 10.98% 19.20% 18.57% 16.53% 15.26% 16.00% Manufacturing Exp. - 215.73 232.08 147.23 125.30 103.70 150.54 145.03 137.05 119.15 101.54 % Of Sales - 17.47% 21.03% 12.39% 9.08% 6.73% 11.30% 12.07% 12.09% 11.02% 11.60% General & Admin Exp. - 123.98 147.90 229.37 594.53 744.66 167.66 153.29 127.77 104.73 88.54 % Of Sales - 10.04% 13.40% 19.30% 43.09% 48.35% 12.58% 12.76% 11.27% 9.69% 10.11% Selling & Distn. Exp. - 122.52 116.12 197.24 108.38 107.77 166.84 157.12 134.03 135.93 116.00 % Of Sales - 9.92% 10.52% 16.60% 7.85% 7.00% 12.52% 13.07% 11.82% 12.58% 13.25% Miscellaneous Exp. - 3.81 3.50 16.26 5.16 2.06 2.58 4.19 0.73 10.97 116.00 % Of Sales - 0.31% 0.32% 1.37% 0.37% 0.13% 0.19% 0.35% 0.06% 1.01% 0.97% EBITDA 77.39 91.11 -50.82 -81.02 21.69 182.44 163.88 101.00 177.70 170.74 116.04 EBITDA Margin 6.37% 7.38% -4.60% -6.82% 1.57% 11.85% 12.30% 8.40% 15.68% 15.80% 13.25% Other Income 49.27 50.19 91.31 98.41 3,278.19 5.50 19.11 20.72 42.38 16.96 12.50 Interest 4.86 5.12 7.85 7.52 8.01 3.36 2.90 3.04 3.19 3.29 4.08 Depreciation 85.94 84.36 81.67 67.37 50.51 43.52 38.79 41.27 45.72 38.34 30.43 PBT 35.85 51.82 -49.02 -57.50 3,241.36 141.07 141.31 77.41 171.17 146.07 94.03 Tax 15.00 17.15 11.97 -33.64 696.23 32.58 29.30 2.13 43.00 32.85 22.77 Tax Rate 41.84% 33.10% -24.42% 58.50% 21.48% 23.09% 21.27% 2.75% 25.12% 22.49% 24.22% PAT 20.87 34.67 -61.00 -23.87 2,545.13 108.49 108.48 75.28 128.16 113.23 71.26 PAT before Minority Interest 20.87 34.67 -61.00 -23.87 2,545.13 108.49 108.48 75.28 128.16 113.23 71.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.72% 2.81% -5.53% -2.01% 184.44% 7.04% 8.14% 6.26% 11.31% 10.48% 8.14% PAT Growth 139.64% - - - 2,245.96% 0.01% 44.10% -41.26% 13.19% 58.90% EPS 2.96 4.92 -8.66 -3.39 361.52 15.41 15.41 10.69 18.20 16.08 10.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 2,697.33 2,647.18 2,731.93 2,761.67 1,130.73 1,027.15 947.42 906.27 812.95 730.05 Share Capital 14.08 14.08 14.08 14.07 18.18 18.17 18.15 18.13 18.09 18.06 Total Reserves 2,675.50 2,628.28 2,714.02 2,747.01 1,111.11 1,007.83 928.41 887.39 793.86 711.27 Non-Current Liabilities 50.27 29.68 26.79 50.07 70.40 63.66 69.27 73.08 73.42 72.20 Secured Loans 0.00 0.00 0.00 0.33 0.44 0.46 0.22 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.49 Long Term Provisions 30.41 23.51 14.60 10.76 25.33 12.58 8.88 7.64 9.19 10.24 Current Liabilities 371.45 348.27 271.50 295.88 301.81 282.61 205.00 227.27 246.34 224.19 Trade Payables 188.57 208.22 192.69 211.51 228.28 189.63 142.63 151.13 159.09 136.78 Other Current Liabilities 168.06 115.02 67.56 60.40 56.73 47.43 36.32 29.71 29.87 29.23 Short Term Borrowings 0.00 15.21 0.00 0.00 0.55 7.90 0.00 0.63 5.72 24.87 Short Term Provisions 14.83 9.81 11.25 23.97 16.25 37.65 26.05 45.80 51.67 33.30 Total Liabilities 3,119.05 3,025.13 3,030.22 3,107.62 1,502.94 1,373.42 1,221.69 1,206.62 1,132.71 1,026.44 Net Block 846.23 824.94 785.16 551.12 464.17 381.20 395.87 393.72 426.22 385.21 Gross Block 1,129.16 1,037.52 939.38 655.08 535.64 414.65 683.53 642.30 637.46 562.43 Accumulated Depreciation 282.93 212.58 154.22 103.96 71.47 33.45 287.67 248.58 211.24 177.22 Non Current Assets 1,813.69 1,520.42 1,177.12 895.56 815.69 744.42 676.73 642.69 671.09 614.20 Capital Work in Progress 567.73 330.84 90.25 235.53 247.26 232.65 118.66 86.31 129.29 111.34 Non Current Investment 287.52 252.77 245.36 86.97 85.16 102.52 117.61 114.25 107.20 91.62 Long Term Loans & Adv. 112.21 111.88 56.36 21.94 19.11 28.05 44.59 48.42 8.38 26.02 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,305.37 1,504.71 1,853.10 2,212.05 687.25 629.00 544.95 563.92 461.63 412.25 Current Investments 236.43 419.10 800.75 895.55 8.00 8.04 35.04 5.67 33.06 14.50 Inventories 386.12 315.57 274.18 207.76 253.98 200.66 186.48 186.24 131.63 141.13 Sundry Debtors 360.48 323.10 331.35 231.74 296.49 264.73 206.19 211.28 212.28 184.82 Cash & Bank 57.59 205.37 191.03 673.61 10.16 10.94 19.71 40.83 16.66 13.86 Other Current Assets 264.75 58.80 63.63 57.89 118.61 144.63 97.52 119.92 68.00 57.93 Short Term Loans & Adv. 207.13 182.77 192.16 145.51 100.40 121.55 80.97 103.50 59.71 51.11 Net Current Assets 933.91 1,156.45 1,581.60 1,916.17 385.44 346.38 339.96 336.65 215.28 188.06 Total Assets 3,119.06 3,025.13 3,030.22 3,107.61 1,502.94 1,373.42 1,221.68 1,206.61 1,132.72 1,026.45

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 2,556.83 2,531.35 2,619.91 2,680.08 1,063.62 954.33 867.52 816.61 727.07 660.58 Share Capital 14.08 14.08 14.08 14.07 18.18 18.17 18.15 18.13 18.09 18.06 Total Reserves 2,535.00 2,512.44 2,601.99 2,665.42 1,044.00 935.01 848.52 797.74 707.98 641.80 Non-Current Liabilities 49.16 43.72 10.10 46.46 64.49 76.02 74.21 97.72 94.31 92.67 Secured Loans 0.00 0.00 0.00 0.33 0.44 22.98 20.35 24.65 20.89 20.47 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.49 Long Term Provisions 30.41 23.51 14.60 10.76 25.33 12.58 8.88 7.64 9.19 10.24 Current Liabilities 505.76 566.73 502.92 463.51 392.62 275.09 211.76 230.32 251.12 233.30 Trade Payables 210.08 250.22 221.41 226.23 210.73 163.95 138.23 150.52 156.63 140.30 Other Current Liabilities 176.97 122.04 68.45 63.03 68.01 60.56 45.86 32.99 36.65 34.28 Short Term Borrowings 100.63 184.03 199.67 150.29 97.62 12.93 1.63 1.04 6.17 25.42 Short Term Provisions 18.09 10.44 13.39 23.97 16.25 37.65 26.05 45.78 51.67 33.30 Total Liabilities 3,111.75 3,141.80 3,132.93 3,190.05 1,520.73 1,305.44 1,153.49 1,144.65 1,072.50 986.55 Net Block 880.42 866.06 806.29 574.45 487.22 402.60 415.99 419.29 447.76 408.39 Gross Block 1,193.56 1,098.27 975.96 689.74 561.37 439.53 724.65 688.25 675.87 599.27 Accumulated Depreciation 313.14 232.21 169.67 115.29 74.15 36.92 308.66 268.96 228.11 190.87 Non Current Assets 1,734.44 1,455.33 1,093.64 853.59 772.27 673.34 589.07 563.97 594.06 547.20 Capital Work in Progress 567.50 330.47 92.39 238.15 249.98 237.13 122.64 90.54 132.20 112.76 Non Current Investment 159.12 134.38 129.20 9.20 9.51 5.54 5.83 5.72 5.72 0.03 Long Term Loans & Adv. 112.89 112.90 56.37 24.05 25.57 28.05 44.61 48.42 8.38 26.02 Other Non Current Assets 14.52 11.52 9.39 7.74 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,377.32 1,686.47 2,039.29 2,336.47 748.46 632.11 564.42 580.68 478.44 439.35 Current Investments 236.43 419.10 800.75 895.55 8.00 8.04 35.04 5.67 33.06 14.50 Inventories 538.34 396.54 338.66 272.86 281.71 230.57 207.68 203.49 143.05 157.96 Sundry Debtors 250.27 390.14 436.05 276.92 315.32 220.09 191.58 196.51 206.95 183.25 Cash & Bank 82.45 233.81 200.99 681.46 16.14 20.13 26.96 52.15 24.64 23.23 Other Current Assets 269.83 63.84 68.65 64.17 127.29 153.28 103.17 122.86 70.75 60.40 Short Term Loans & Adv. 207.62 183.04 194.18 145.51 98.80 122.77 82.25 105.67 61.73 53.14 Net Current Assets 871.56 1,119.74 1,536.37 1,872.95 355.84 357.02 352.66 350.36 227.32 206.05 Total Assets 3,111.76 3,141.80 3,132.93 3,190.06 1,520.73 1,305.45 1,153.49 1,144.65 1,072.50 986.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity -32.50 -41.84 -251.30 -66.25 140.78 116.58 88.03 86.87 180.30 129.26 PBT 65.65 -63.81 -19.11 3,249.34 131.60 124.17 81.50 178.82 162.45 105.24 Adjustment 49.68 -6.17 -7.08 -3,214.36 72.37 56.10 36.30 20.38 46.82 37.81 Changes in Working Capital -147.51 25.49 -217.91 -103.24 -35.89 -32.73 -11.59 -74.94 5.77 8.92 Cash after chg. in Working capital -32.19 -44.49 -244.10 -68.27 168.08 147.55 106.21 124.26 215.04 151.97 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.31 2.65 -7.20 2.01 -27.30 -30.97 -18.17 -37.39 -34.74 -22.71 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -80.39 -35.59 -322.63 1,648.30 -131.91 -86.73 -62.18 35.22 -126.60 -110.97 Net Fixed Assets -328.53 -338.73 -139.02 -107.71 -135.60 154.89 -73.58 38.14 -92.98 -106.47 Net Investments 147.92 374.24 -63.59 -889.36 17.40 42.09 -32.73 20.34 -34.14 -5.98 Others 100.22 -71.10 -120.02 2,645.37 -13.71 -283.71 44.13 -23.26 0.52 1.48 Cash from Financing Activity -45.19 -21.02 -44.89 -929.51 -8.95 -38.63 -46.97 -97.92 -50.90 -14.87 Net Cash Inflow / Outflow -158.07 -98.45 -618.82 652.53 -0.08 -8.77 -21.12 24.17 2.80 3.42 Opening Cash & Equivalents 203.08 188.66 660.31 7.77 7.86 19.71 40.83 16.66 13.86 10.44 Closing Cash & Equivalent 52.60 203.08 188.66 660.31 7.77 10.94 19.71 40.83 16.66 13.86

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 33.10 19.82 -327.77 -112.34 68.19 111.91 78.10 86.73 171.23 124.08 PBT 51.48 -48.21 -57.44 3,241.14 141.25 137.68 77.41 171.17 146.07 94.03 Adjustment 65.65 18.79 6.80 -3,207.66 53.31 39.65 35.57 18.74 47.15 39.37 Changes in Working Capital -69.67 53.58 -264.94 -146.67 -98.65 -34.16 -16.49 -66.32 13.05 13.51 Cash after chg. in Working capital 47.46 24.15 -315.57 -113.20 95.91 143.16 96.49 123.58 206.27 146.91 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.36 -4.34 -12.20 0.86 -27.72 -31.25 -18.39 -36.85 -35.04 -22.83 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -73.56 -35.91 -286.01 1,648.33 -127.87 -85.33 -52.34 35.70 -118.45 -101.80 Net Fixed Assets -328.53 -338.73 -139.02 -107.71 -135.60 154.89 -73.58 38.14 -92.98 -106.47 Net Investments 147.92 374.24 -63.59 -889.36 17.40 42.09 -32.73 20.34 -34.14 -5.98 Others 107.05 -71.42 -83.40 2,645.40 -9.67 -282.31 53.97 -22.78 8.67 10.65 Cash from Financing Activity -121.19 -62.30 -2.42 -881.13 59.23 -33.42 -50.95 -94.92 -51.38 -14.21 Net Cash Inflow / Outflow -161.65 -78.40 -616.19 654.86 -0.46 -6.84 -25.19 27.51 1.41 8.07 Opening Cash & Equivalents 231.52 197.05 666.07 11.21 11.67 26.96 52.15 24.64 23.23 15.16 Closing Cash & Equivalent 77.46 231.52 197.05 666.07 11.21 20.13 26.96 52.15 24.64 23.23

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 382.01 375.30 387.60 392.55 124.27 112.94 104.28 99.92 89.76 80.75 ROA 1.76% -1.86% 0.29% 110.90% 7.22% 7.74% 5.30% 11.61% 12.00% 8.49% ROE 2.03% -2.10% 0.32% 131.43% 9.64% 10.19% 6.95% 15.82% 16.82% 11.73% ROCE 2.50% -2.32% -0.67% 167.06% 12.33% 12.75% 9.04% 21.01% 20.65% 14.59% Fixed Asset Turnover 1.04 0.92 1.22 2.07 2.99 2.25 1.66 1.64 1.69 1.52 Receivable days 110.99 132.06 105.30 78.26 72.16 69.53 69.33 73.49 71.54 83.25 Inventory Days 113.93 119.00 90.13 68.41 58.46 57.16 61.90 55.15 49.14 62.43 Payable days 75.71 82.50 82.64 118.77 140.05 63.62 59.84 69.69 71.38 71.47 Cash Conversion Cycle 149.21 168.55 112.80 27.91 -9.43 63.06 71.39 58.95 49.31 74.22 Total Debt/Equity 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.07 Interest Cover 51.47 -48.78 -29.97 1027.03 66.88 55.19 35.41 73.06 66.46 32.90

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 362.05 358.85 371.69 380.95 116.88 104.93 95.48 90.02 80.27 73.06 ROA 1.11% -1.94% -0.75% 108.06% 7.68% 8.82% 6.55% 11.56% 11.00% 7.63% ROE 1.37% -2.37% -0.90% 136.04% 10.77% 11.92% 8.95% 16.62% 16.34% 11.16% ROCE 2.12% -1.49% -1.77% 162.77% 13.42% 14.97% 9.29% 21.84% 20.13% 14.03% Fixed Asset Turnover 1.08 1.06 1.43 2.21 3.08 2.32 1.71 1.67 1.71 1.55 Receivable days 94.63 136.61 109.51 78.30 63.41 55.72 58.55 64.53 65.42 76.34 Inventory Days 138.14 121.57 93.93 73.33 60.67 59.32 62.03 55.42 50.47 63.88 Payable days 70.25 76.39 73.41 94.97 104.25 52.00 52.61 62.52 65.77 65.64 Cash Conversion Cycle 162.51 181.78 130.03 56.65 19.82 63.05 67.97 57.43 50.11 74.58 Total Debt/Equity 0.04 0.07 0.08 0.06 0.09 0.04 0.03 0.03 0.04 0.11 Interest Cover 11.12 -5.25 -6.64 405.79 43.00 48.57 26.45 54.66 45.40 24.06

Top Investors:

hdfc small cap fund

krishnaraj venkataraman

Annual Reports:

News Update:

Unichem Laboratories gets USFDA’s nod for Metformin Hydrochloride Extended-Release Tablets
13th Aug 2021, 09:12 AM

The product will be commercialized from Unichem's Goa Plant
Read More
Unichem Laboratories reports consolidated net loss of Rs 11 crore in Q1
2nd Aug 2021, 11:19 AM

Total consolidated income of the company increased by 6.06% at Rs 313.70 crore for Q1FY22
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback